Please login to the form below

biosimilars

This page shows the latest biosimilars news and features for those working in and with pharma, biotech and healthcare.

Amgen strikes $240m autoimmune deal with Evoq Therapeutics

Otezla fits right into Amgen’s existing psoriasis and anti-inflammatory product range, which includes Enbrel (etanercept) and Amgevita, its biosimilar of AbbVie’s Humira (adalimumab) which is approved and already

Latest news

Roche gets EU approval for fixed-dose Herceptin/Perjeta combination

Herceptin has been hit by biosimilar competition, with much of the market share taken from Roche’s drug treatment by generic rivals from Amgen, Mylan, Pfizer, Teva and Merck &Co. ... In Roche’s half-year report for 2020, sales of Herceptin had
Pfizer CEO says COVID-19 vaccine efficacy data could come ‘soon’

Global revenues for its biosimilar also reach $424m, up 80% operationally, driven mostly by recent oncology launches of Ruxience (rituximab), Zirabev (bevacizumab) and Trazimera (trastuzumab) in the US and other global
Roche’s Ocrevus boasts positive long-term data in MS

The MS market has long been dominated by Ocrevus, which is approved for use in both relapsing forms of MS and primary progressive MS, although it is facing biosimilar competition in
Novartis builds its case for novel MS treatment ofatumumab

biosimilar competition in the US and Europe.
Roche cites COVID-19 and biosimilars in Q2 decline

Much of that decline can be attributed to increasing biosimilar competition to three of Roche’s key cancer therapies – Herceptin (trastuzumab), Avastin (bevacizumab) and Rituxan (rituximab). ... We originally had predicted a biosimilar impact of

More from news
Approximately 137 fully matching, plus 352 partially matching documents found.

Latest Intelligence

Growing evidence supports the important role of biosimilars in healthcare

An estimated 1.2 million US patients could gain access to biologics by 2025 as the result of increasing biosimilar availability. ... Ongoing support for biosimilars is imperative. Biosimilars are typically discounted by 20-40% from the price of a
The US celebrates five years of biosimilars on the market – a look to the past, present and future

However, various barriers continue to inhibit biosimilars from realising their full potential, driven by patent disputes and formulary challenges which prevent more robust biosimilar adoption. ... Additionally, existing policies restrict the ability of
Could formulary intelligence be your brand differentiator?

Abasaglar – a biosimilar to Lantus (diabetes), offering a money-saving value proposition for medicines management. ... This sample encompassed a range of product profiles – from money-saving biosimilars and branded generics to novel therapeutic
Cortellis Drugs to Watch in 2020 report

It faces multiple competitors across both oral and injectable therapies, as well as a stiff pricing environment due to the presence of generics and biosimilars. ... The drug must leverage its competitive profile as it will face significant competition
20 for 2020 – Five pharma leaders to watch in 2020

biosimilars and other lower-cost drugs and health concerns relating to vaping products.

More from intelligence
Approximately 14 fully matching, plus 61 partially matching documents found.

Latest appointments

New hires at Bayer, Eisai and Accord Healthcare

and biosimilar specialists,” he added.
Ashfield, Health Unlimited and Ashley Communications add to their teams

Van Weperen was most recently at diabetes giant Novo Nordisk, where he worked on delivering insulin and GLP1 biosimilar defence strategies, leading Novo’s UK diabetes team.
Lilly bolsters its oncology team

Furthermore, she has been on the forefront of research in oncology vaccines, immuno-oncology and biosimilars, giving her the unique expertise that will be pivotal in helping us continue to develop
PharmaLex appoints Zabin Younes as associate director

She joins the group as an associate director and arrives from ERA Consulting - a biopharmaceutical consultancy based in the UK - where she picked up experience in the biosimilar development lifecycle. ... With experience spanning over 15 years, Younes’
GW Pharmaceuticals strengthens research and development team

Knappertz has previously held several leadership positions including vice president of clinical development for multiple sclerosis, oncology and biosimilar products at Teva, and numerous clinical and medical roles at Bayer and

More from appointments
Approximately 1 fully matching, plus 15 partially matching documents found.

Latest from PMHub

Are biobetters a market access opportunity?

This produces time pressure for biobetters to make it to market before a biosimilar, to avoid the downward price pressure a biosimilar creates. ... Moreover, biobetters will need to enter the market before the exclusivity period of the patented reference
How to weather the pricing competiton

deal. The simulated market becomes highly competitive with the entrance of a better value product and then later a biosimilar/generic competitor.
Launch Excellence 2020

In the past year, the competition in biosimilars and complex generics has complicated the launch landscape.
The 'winner takes all' pricing game

Conclusions. Pharmaceutical tendering will stay as a key procurement approach for pharmaceutical products, especially for hospital products but also in outpatient settings for generics/biosimilars or other segments of products with
How ready are you for launch?

Specifically, it has focused its efforts on increasing competition in biosimilars and complex generics, which are difficult to copy, in a bid to increase competition and drive down prices.

More from PMHub
Approximately 12 fully matching, plus 26 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Healthcare Senior Account Manager: Competitive

Sales Director, Healthcare communications agency, London/ SE UK: Six figure salary

Healthcare Account Director: Competitive

Account Manager Healthcare / Pharmaceutical Sector: Negotiable Salary

Medical Editor: Competitive

Account Director – Creative Healthcare Communications: Competative

Healthcare Lead Copywriter: Competitive

PMHub

Add my company

3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

2020 - a year to remember or forget?: 2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
The search for effective drug treatments for COVID-19: PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...
AstraZeneca’s focus on diagnosing and managing chronic kidney disease: People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...